RECENT NEWS
Novo Nordisk's Ozempic successor disappointed Wall Street again
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Big Pharma wants to bring back a tax break that could save it $15 billion
Ozempic competitor in the works at Amgen reaches late-stage clinical trials